RESUMEN
With an inversion center at the mid-point of the two Re(III) atoms, the title compound, [Re2Cl2{O2C(CH2)2CH3}4], exhibits a paddle-wheel or lantern-type structure with four n-butyrate groups bridging two Re(III) atoms in a syn-syn fashion. The axial chloride ligands together with the Re-Re quadruple bond [2.2330â (3)â Å] complete an essentially octa-hedral geometry around each Re(III) atom. There is little distortion, with an Re-Re-Cl bond angle of 176.18â (3)° and typical cis-O-Re-O bond angles ranging from 89.39â (11) to 90.68â (11)°. There are two mol-ecules in the unit cell, and no significant inter-molecular inter-actions were noticed between mol-ecules in the crystal.
RESUMEN
The title compound, [Ru(C19H13N5)2](PF6)2·3C4H10O, was obtained from the reaction of Ru(bimpy)Cl3 [bimpy is 2,6-bis-(1H-benzimidazol-2-yl)pyridine] and bimpy in refluxing ethanol followed by recrystallization from diethyl ether/aceto-nitrile. At 125â K the complex has ortho-rhom-bic (Pca21) symmetry. It is remarkable that the structure is almost centrosymmetric. However, refinement in space group Pbcn leads to disorder and definitely worse results. It is of inter-est with respect to potential catalytic reduction of CO2. The structure displays N-Hâ¯O, N-Hâ¯F hydrogen bonding and significant π-π stacking and C-Hâ¯π stacking inter-actions.
RESUMEN
Achiral [Ru2(µ-O2CR)4(MeOH)2](PF6) (R = CH3 or C6H5) reacts with the chiral diphosphines R,R- and S,S-Chiraphos (two chiral centers on ligand between the coordinating P atoms) and R-Prophos (one chiral center on ligand between the coordinating P atoms) leading to a disassembly of the paddlewheel core and the highly diastereoselective production of Λ-[Ru(η(2)-O2CC6H5)(η(2)-R,R-Chiraphos)2](PF6) (Λ-R,R-III), Δ-[Ru(η(2)-O2CC6H5)(η(2)-S,S-Chiraphos)2](PF6) (Δ-S,S-III) (the R = CH3 complexes of Chiraphos were reported in a earlier communication in this journal), and Λ-[Ru(η(2)-O2CCH3)(η(2)-R-Prophos)2](PF6) (Λ-R,R-VI), respectively, in high yield and purity. Reactions of the same starting material with R,R- and S,S-o-tolyl-Dipamp (chiral centers are the coordinating P-atoms) lead to an inversion in the chirality-at-metal producing Λ-[Ru(η(2)-O2CC6H5)(η(2)-S,S-o-tolyl-Dipamp)2](PF6) (Λ-S,S-IV), Δ-[Ru(η(2)-O2CC6H5)(η(2)-R,R-o-tolyl-Dipamp)2](PF6) (Δ-R,R-IV), Λ-[Ru(η(2)-O2CCH3)(η(2)-S,S-o-tolyl-Dipamp)2](PF6) (Λ-S,S-V), and Δ-[Ru(η(2)-O2CCH3)(η(2)-R,R-o-tolyl-Dipamp)2](PF6) (Δ-R,R-V). X-ray crystallography of all but Λ-S,S-V and Δ-R,R-V and solid-state circular dichroism (CD) show that only the indicated diastereomers are present in the solid-state. Solution CD measurements and (31)P NMR also indicate their predominance in solution.
RESUMEN
In the title compound, [Sn(C13H11N4S)(CH3)3], the Sn(IV) atom is coordinated by an S atom from the 1,5-diphenyl-thio-carbazonato (L) ligand [Sn-S 2.4710â (6)â Å] and by three methyl groups [Sn-C 2.123â (3)-2.130â (2)â Å] in a distorted tetra-hedral geometry. The aromatic rings of the L ligand form a dihedral angle of 2.1â (1)°.
RESUMEN
The title compound, [Ru2(µ-O2CCH3)4(C5H4ClN)2]PF6·C2H4Cl2, was obtained via a rapid substitution reaction of 3-chloro-pyridine for water in [Ru2(µ-O2CCH3)4(H2O)2]PF6 in 2-propanol and subsequent crystallization from a di-chloro-ethane solution. The cationic diruthenium(II,III) tetra-acetate core lies on a crystallographic inversion center with Ru-Ru and Ru-N bond lengths of 2.2738â (3) and 2.2920â (17)â Å, respectively. The Ru-Ru-N bond angle is close to linear at 176.48â (4)°, and a significant π-stacking inter-action of 3.5649â (16)â Å is seen between overlapping pyridine rings of adjacent cations.
RESUMEN
[Ru(2)(µ-O(2)CCH(3))(4)(MeOH)(2)](PF(6)) reacts with chiral diphosphines (R,R)- and (S,S)-chiraphos, leading to disassembly and production of the enantiomers Λ-[Ru(η(2)-O(2)CCH(3))(η(2)-(R,R)-chiraphos)(2)](PF(6)) and Δ-[Ru(η(2)-O(2)CCH(3))(η(2)-(S,S)-chiraphos)(2)](PF(6)) in high yield and purity. X-ray crystallography and solid-state circular dichroism (CD) show that only the indicated isomers are present in the solid state. Solution CD measurements also indicate their predominance in solution.
RESUMEN
The title compound, [Ru(2)(CH(3)CO(2))(4)(C(6)H(4)N(2))(2)]PF(6)·C(2)H(4)Cl(2), was obtained via a rapid substitution reaction in 2-propanol whereby 3-cyano-pyridine replaces the axial water mol-ecules in the diaquatetra-µ-acetato-diruthenium(II,III) hexa-fluorido-phosphate starting material. The product rapidly precipated and crystals were grown from 1,2-dichloro-ethane. The 1,2-dichloro-ethane mol-ecule of solvation exhibits disorder with two different orientations [occupancy ratio 0.51â (6):0.49â (6)]. All three parts, the cation, the anion and the disordered solvent mol-ecule lie on crystallographic inversion centers. The Ru-Ru bond length of 2.2702â (6)â Å fits nicely into the range seen for similar complexes and correlates well with the reduction potential of the complex and donor strength of the axial ligand, 3-cyano-pyridine, as postulated in a previous study [Vamvounis et al. (2000 â¶). Inorg. Chim. Acta, 305, 87-98]. The 3-cyano-pyridine ligands orient themselves in an anti configuration with respect to each other and the Ru-Ru-N angle [174.27â (7)°] is close to being linear.
RESUMEN
The title compound, C(23)H(23)NO(5)·CH(2)Cl(2), was obtained via the alkyl-ation of the 12-hydr-oxy-2,3,8,9-tetra-methoxy-benzo[c]phenanthridine salt. The benzo[c]phenanthridine ring system is essentially planar, with a mean out-of-plane deviation of 0.026â Å. A dicloromethane mol-ecule of solvation is present and located between the sheets of phenanthridine mol-ecules, preventing any significant inter-molecular hydrogen-bonding or π-π inter-actions.
RESUMEN
BACKGROUND: Mixed-valent diruthenium tetracarboxylate complexes were shown to have slight antineoplastic activity against P388 leukemia cell lines. However these complexes suffered from poor water-solubility, which may have detrimentally affected their activity. MATERIALS AND METHODS: Mixed-valent diruthenium tetracarboxylates of the type [Ru2(O2CR)4(L)2] (PF6) with L = imidazole, 1-methylimidazole and H2O when R = CH3, L = ethanol when R = Fc (ferrocenyl) or Fc-CH=CH- and of the type M3[Ru2(O2CR)4(H2O)2]4H2O, M = Na+ when R = m-C6H4SO3- and M = K+ when R = p-C6H4SO3-, were tested for cytotoxicity against HeLa and multidrug resistant CoLo 320DM human cancer cell lines. Cell survival was measured by means of the colorometric 3-(4,5dimethylthiazol-2-yl)-diphenyltetrazodium bromide assay. RESULTS: The mean drug concentration from 3 experiments causing 50% cell killing, ie, IC50 values, varied between 120 and 950 micromol dm(-3). CONCLUSION: The antineoplastic activity of the highly water-soluble m-sulpho derivative was the highest, while the poorly water-soluble imidazole derivatives did not exhibit any cytotoxic properties. The CoLo 320DM cancer cells were 5 times more prone to drug-induced cell death than the HeLa cells.
Asunto(s)
Antineoplásicos/toxicidad , Compuestos Organometálicos/toxicidad , Rutenio/toxicidad , Animales , Antineoplásicos/química , Ensayos de Selección de Medicamentos Antitumorales , Células HeLa/efectos de los fármacos , Humanos , Leucemia P388/tratamiento farmacológico , Ratones , Compuestos Organometálicos/química , Rutenio/químicaRESUMEN
The Fe(II) of the binuclear Fe(II)Fe(III) active site of pig purple acid phosphatase (uteroferrin) has been replaced in turn by five M(II) ions (Mn(II), Co(II), Ni(II), Cu(II), and Zn(II)). An uptake of 1 equiv of M(II) is observed in all cases except that of Cu(II), when a second more loosely bound Cu(II) is removed by treatment with edta. The products have been characterized by different analytical procedures and by UV-vis spectrophotometry. At 25 degrees C, I = 0.100 M (NaCl), the nonenzymatic reactions with H(2)PO(4)(-) give the mu-phosphato product, and formation constants K/M(-1) show an 8-fold spread at pH 4.9 of 740 (Mn), 165 (Fe), 190 (Co), 90 (Ni), 800 (Cu), 380 (Zn). The variations in K correlate well with stability constants for the complexing of H(2)PO(4)(-) and (CH(3)O)HPO(3)(-) with M(II) hexaaqua ions. At pH 4.9 with [H(2)PO(4)(-)] > or = 3.5 mM rate constants k(obs) decrease, and an inhibition process in which a second [H(2)PO(4)(-)] coordinates to the dinuclear center is proposed. The mechanism considered accounts for most but not all of the features displayed. Thus K(1) values for the coordination of phosphate to M(II) are in the range10-60 M(-1), whereas K(2) values for the bridging of the phosphate to Fe(III) are in the narrower range 7.8-12.4. From the fits described K(i) approximately 10(3) M(-1) for the inhibition step, which is independent of the identity of M(II). Values of k(obs) decrease with increasing pH, giving pK(a) values which are close to 3.8 and independent of M(II) (Fe(II), Zn(II), Mn(II)). The acid dissociation process is assigned to Fe(III)-OH(2) to Fe(III)-OH(-), where OH(-) is less readily displaced by phosphate.